/sent on behalf of
Dr. Ben Albensi
DEMENTIA JOURNAL CLUB
Wednesday, April 28th, 2021
12:00 PM (noon)
Zoom link
https://us02web.zoom.us/j/83383153871?pwd=YVVxUXdHWmljUlV0elJSSEFITStPQT09
Meeting ID: 833 8315 3871
Passcode: 744024
Dr. R. Scott Turner, M.D., Ph.D.
Vice Chair for Clinical Research
Professor, Department of Neurology
Director, Memory Disorders Program - Georgetown University
Dr. Turner's research is focused on developing new treatments and biomarkers for neurodegenerative diseases of aging, particularly Mild Cognitive Impairment and dementia due to Alzheimer's disease. Dr. Turner is on the steering committees of the Alzheimer's Disease Cooperative Study (ADCS) and the Alzheimer's Therapeutic Research Institute (ATRI), and is a site PI for the NIH-funded Alzheimer's Clinical Trials Consortium (ACTC) and Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD). He is PI or Site PI on numerous multi-center, randomized, placebo-controlled clinical trials, including Resveratrol for Alzheimer's disease and Nilotinib for Alzheimer's disease.
All are welcome to attend!
For more information contact Dr. Ben Albensi, balbensi@sbrc.ca mailto:balbensi@sbrc.ca
******************************************
http://www.manitobaneuroscience.ca/
https://www.facebook.com/manitobaneuroscience/?fref=ts https://www.instagram.com/manitobaneuroscience/ https://twitter.com/manitobaneuro
